Adults using a GLP-1 had an increase in GFR from 50.48 mL/min/1.73 m 2 at baseline to 53.44 mL/min/1.73 m 2 at 6 months, whereas the control group had a decrease from 43.4 mL/min/1.73 m 2 at baseline to 40.84 mL/min/1.73 m 2 at 6 months ( P = .03)
Dr Joshua Siegel, a co-author of the work from Washington University School of Medicine in St Louis, said the research may also bring benefits to companies testing novel psychedelics and similar, but non-hallucinogenic, drugs
Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan
Glutathione, often referred to as the bodys 'master antioxidant', not only protects cells from oxidative damage but also helps regenerate other antioxidants, strengthening overall cellular defence
another class of diabetes medications, SGLT2s
I have been using Dr